Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05422430 · ClinicalTrials.gov registry record · NA

Rebreathing-induced Hypoxia and Glucose Levels

A NA study of Hypoxemia, sponsored by University of Texas at Austin.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT05422430 is a NA study of Hypoxemia that is active but no longer recruiting, run by University of Texas at Austin. The registered enrollment target is 20 participants, below the 494-participant average among 10 other Hypoxemia trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05422430, a NA study of Hypoxemia, is active but no longer recruiting, sponsored by University of Texas at Austin.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The aim of this research project is to determine the effect of repeated maximal voluntary apneas on glucose uptake during an oral glucose tolerance test in healthy individuals, individuals with prediabetes and patients with type 2 diabetes.

Conditions Studied

Interventions

  • BEHAVIORAL Rebreathing-induced hypoxia
  • BEHAVIORAL Spontaneous breathing

Study Locations (1)

Texas

  • The Unviersity of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2021-10-21
Est. Completion 2025-04-30
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT05422430

The ClinicalTrials.gov registry entry for NCT05422430 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 494-participant average among 10 other Hypoxemia trials with a reported enrollment target (96% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypoxemia appearing as the primary indexed condition, and to 2 interventions - of which Rebreathing-induced hypoxia is the first listed.

NCT05422430 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05422430 about?

NCT05422430 is a clinical study titled "Rebreathing-induced Hypoxia and Glucose Levels". The aim of this research project is to determine the effect of repeated maximal voluntary apneas on glucose uptake during an oral glucose tolerance test in healthy individuals, individuals with prediabetes and patients with type 2 diabetes.

What is the current status of trial NCT05422430?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2021-10-21. Estimated completion is 2025-04-30.

What conditions does trial NCT05422430 study?

This clinical trial studies the following conditions: Hypoxemia.

What interventions are being tested in trial NCT05422430?

The interventions under investigation include: Rebreathing-induced hypoxia (BEHAVIORAL), Spontaneous breathing (BEHAVIORAL).

Who is sponsoring clinical trial NCT05422430?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05422430 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypoxemia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.